John Lansing's Trending123
John Lansing's Trending123
Username: Password: Login
Trade Talk E-Letter Products & Services Trading Tools Portfolios Members Home
Enter Symbol:
INSPIRE PHARMACEUTICALS INC
Drug Manufacturers Other
ISPH @ Yahoo Finance
ISPH Option @ Yahoo Finance
Stock Details
Current Price High Value Change Percent Change Dividend Previous Close
$ 2.77 $ 3.04 $ -0.34 -3.86% 0.00 $ 3.11
Opening Price Low Volume Market Cap Average Volume P/E
$ 3.04 $ 2.54 674,123 156.46M 376,171 0.00
Pivot Table
R2 R1 Pivot S1 S2
3.28 3.02 2.78 2.52 2.28

stock chart

Inspire Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovery, development, and commercialization of prescription pharmaceutical products in the ophthalmic and respiratory therapeutic areas. It has product candidates in various stages of clinical development and various programs in preclinical development. The company's clinical product candidates are based on proprietary technology relating to P2 receptors. Its products in clinical development include INS365 Ophthalmic for treating dry eye disease and corneal wound healing; INS37217 Respiratory for the treatment of cystic fibrosis; INS37217 Ophthalmic for the treatment of retinal disease; and INS50589 Antiplatelet for use in acute cardiac care. In addition, the company has rights to co-promote Elestat, for the treatment of allergic conjunctivitis; and Restasis, for the treatment of dry eye disease in the United States under collaborative agreements with Allergan, Inc. It also has collaborative partnerships with Santen Pharmaceutical Co., Ltd., and Cystic Fibrosis Foundation Therapeutics, Inc., as well as license agreements with the University of North Carolina at Chapel Hill and Wisconsin Alumni Research Foundation. The company was incorporated in 1993 and is based in Durham, North Carolina.
  • Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
  • Provide you stock picks (breakouts) and market direction to help you become
    more profitable.

  • Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
  • Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
  • Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More